Sponsors
AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test
The companies previously agreed to jointly develop AccuStem's recurrence predictor assay for patients with breast cancer.
All children and adolescents with cancer in Ireland, including those who relapse following treatment, will be offered enrollment in the project.
Caris Life Sciences, MiBA Partner on Physician Education for Molecular Cancer Testing
The companies will combine information from each other's databases to advance personalized care and to educate providers.
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development
Pfizer intends to use Guardant's blood-based tests in global clinical trials, with specific plans to evaluate the clinical utility of its Reveal assay as clinical trial surrogate endpoint.
Health Insurance Coverage for Biomarker Testing Becomes Law in New Jersey
State-regulated insurers in New Jersey must now cover biomarker testing for diagnosis, treatment, and monitoring.
Dec 2, 2024